Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medifast (MED) Income from Continuing Operations (2016 - 2025)

Medifast's Income from Continuing Operations history spans 16 years, with the latest figure at 18115000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 2437.42% year-over-year to 18115000.0; the TTM value through Dec 2025 reached 18671000.0, down 1003.73%, while the annual FY2025 figure was 18672000.0, 994.68% down from the prior year.
  • Income from Continuing Operations reached 18115000.0 in Q4 2025 per MED's latest filing, down from 2257000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 46963000.0 in Q2 2021 to a low of 18115000.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 19520350.0, with a median of 24824500.0 recorded in 2022.
  • The largest YoY upside for Income from Continuing Operations was 130.35% in 2025 against a maximum downside of 2437.42% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 34023000.0 in 2021, then dropped by 22.06% to 26518000.0 in 2022, then plummeted by 77.24% to 6035000.0 in 2023, then tumbled by 87.16% to 775000.0 in 2024, then plummeted by 2437.42% to 18115000.0 in 2025.
  • Per Business Quant, the three most recent readings for MED's Income from Continuing Operations are 18115000.0 (Q4 2025), 2257000.0 (Q3 2025), and 2475000.0 (Q2 2025).